Effect of Hypnobreastfeeding Education in High-Risk Pregnant Women

December 1, 2025 updated by: Amasya University

The Effect of Hypnobreastfeeding Education Given to High-Risk Pregnant Women on Anxiety Levels, Infant Feeding Intention, Postpartum Perception of Insufficient Milk, and Breastfeeding Adaptation

It is thought that hypnobreastfeeding training given to high-risk pregnant women will reduce anxiety levels, increase lactation, encourage breastfeeding, reduce the perception of insufficient milk, and facilitate adaptation to the postpartum breastfeeding process. According to the results of the power analysis, at least 68 high-risk pregnant women, 34 experimental and 34 control, should be included in the study. Data will be collected with the "Pregnancy Information Form", "Anxiety Assessment Scale", " Infant Feeding Intention Instrument", "Postpartum Information Form", "Perception of Insufficient Milk Questionnaire" and "Breastfeeding Adaptation Scale". In the research, hypnobreastfeeding training will be applied by the researcher to the high-risk pregnant women in the experimental group.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Hypnobreastfeeding training provided to high-risk pregnant women is believed to reduce anxiety, increase lactation, encourage breastfeeding, reduce the perception of insufficient milk supply, and facilitate postpartum breastfeeding adaptation. This will ensure the baby receives adequate and healthy nutrition and the mother's self-confidence increases. Furthermore, hypnobreastfeeding training will contribute to a more comfortable, informed, and peaceful breastfeeding experience for the mother. This will positively impact both the pregnancy and the health of both mother and baby. The study was planned to evaluate the effects of hypnobreastfeeding training given to high-risk pregnant women on anxiety levels, breastfeeding intentions, postpartum perception of insufficient milk, and breastfeeding adaptation. According to the results of the power analysis, at least 68 high-risk pregnant women, 34 experimental and 34 control, should be included in the study. Data will be collected with the "Pregnancy Information Form", "Anxiety Assessment Scale", " Infant Feeding Intention Instrument", "Postpartum Information Form", "Perception of Insufficient Milk Questionnaire" and "Breastfeeding Adaptation Scale". In the research, hypnobreastfeeding training will be applied by the researcher to the high-risk pregnant women in the experimental group.

Study Type

Interventional

Enrollment (Estimated)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
      • Amasya, Turkey (Türkiye), 05000
        • Recruiting
        • Amasya University
        • Contact:
          • Emine İBİCİ AKÇA
          • Phone Number: 0 358 211 50 05

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • High-risk primiparous pregnant women
  • Those with 28-34 weeks of pregnancy
  • Those who volunteered to participate in the study
  • Those who can read and write Turkish

Exclusion Criteria:

  • Those with communication disabilities
  • Those with psychiatric and mental illnesses
  • Those who have an obstacle to breastfeeding
  • Those who have previously attended a birth preparation class
  • Those who receive breastfeeding-related training and consultancy
  • Those who gave birth prematurely
  • Those with anomalies in their babies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: Experimental group
Hypnobreastfeeding Education
Behavioral: Hypnobreastfeeding Education
Monitoring anxiety and breastfeeding intention in pregnancy, and assessing perception of insufficient milk supply, and breastfeeding adaptation in postpartum period

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety Assessment Scale
Time Frame: At the end of the 1 months
The minimum score that can be obtained from the scale is "10", the maximum score is "50", and as the score obtained from the scale increases, anxiety levels also increase.
At the end of the 1 months
Infant Feeding Intention Instrument
Time Frame: At the end of the 1 months
The minimum score that can be obtained from the scale is "0", the maximum score is "16", and as the score obtained from the scale increases, intention to exclusively breastfeed the baby levels also increase.
At the end of the 1 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perception of Insufficient Milk Questionnaire
Time Frame: Postpartum 24-48 hours, postpartum 2nd week and postpartum 4th week
The minimum score that can be obtained from the scale is "0", the maximum score is "50", and as the score obtained from the scale increases, perception of milk sufficiency levels also increase.
Postpartum 24-48 hours, postpartum 2nd week and postpartum 4th week
Breastfeeding Adaptation Scale
Time Frame: Postpartum 24-48 hours, postpartum 2nd week and postpartum 4th week
The minimum score that can be obtained from the scale is "27", the maximum score is "135", and as the score obtained from the scale increases, breastfeeding adaptation levels also increase.
Postpartum 24-48 hours, postpartum 2nd week and postpartum 4th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Amasya University

Investigators

  • Principal Investigator: Emine İbici Akça, PhD, Amasya University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2025

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

November 21, 2025

First Submitted That Met QC Criteria

December 1, 2025

First Posted (Actual)

December 15, 2025

Study Record Updates

Last Update Posted (Actual)

December 15, 2025

Last Update Submitted That Met QC Criteria

December 1, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2025000162

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Feeding

Clinical Trials on Hypnobreastfeeding Education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe